ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

A RANDOMISED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFECT OF SHATAPUTI ABHRAKA BHASMA IN KSHEENA RETAS VIS-A-VIS OLIGOSPERMIA

Journal: International Journal of Advanced Research (Vol.12, No. 01)

Publication Date:

Authors : ; ;

Page : 142-148

Keywords : Ksheena Retas Oligospermia Shataputiabhrakabhasma;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Background: Ksheena retas is a condition where Shukra is moderately decreased, especially in the middle age due to etiology undefined in this type, the body growth, pubertal development and level of Shukra may be normal initially until the etiological factors bring about a fall.Here the cause could be Aharajanya (Katu, Kashaya Rasa), Viharajanya (Abhighata), Vyadhikarshaaa etc. it leads to qualitative or quantitative decrease in the retas.In the present context ksheenaretas can be taken as quantitative decrease in the sperm count. Oligospermia is defined as a reduction in the sperm count below 20 million. it is a major cause of male infertility which is characterized by reduced level of sperm. In the literature, it is mentioned as alpamatrasnehapana (24ml) act as deepana and vrishya.Shataputi Abhraka Bhasma is mentiond as param vrushya and shukrala in the literature in the present study this ShataputiabhrakaBhasma is administerd as trial drug. so an attempt was made in the present study to evaluate the efficacy of shataputi Abhraka Bhasma in trial group B and shatavaryadigritha(indigenous formulation) in control group A. Objective:To evaluate the effect of ShataputiAbhraka Bhasma in ksheenaretas vis-a-vis Oligospermia. Method: It is a Randomised controlled clinical study with pre and post-test design. Shatavaryadighrita (indigenous formulation) prepared was administerdin group A for 30 days. AndShataputiabhraka Bhasmain group B for 30 days. Results: Mean sperm count of 13.125mill/ml was increased in control group A and mean sperm count of 2.7143mill/ml was decreased in trial group B after the intervention. Conclusion: it can be concluded from the result that control drug shatavaryadigritha is effective in the management of Ksheena retas and Shataputi Abhraka Bhasma proved insignificant.

Last modified: 2024-01-27 15:25:57